Schedule 13D ownership disclosure

Flexion Therapeutics Inc

Security class unavailable · CUSIP: 33938J106

Event date: 2016-06-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,511,670
Percent of class
13.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-128383
Form type
SC 13D/A
Filer
Flexion Therapeutics Inc
CIK
CIK 1419600
Filed
Jun 21, 2016
Reporting period
Jun 08, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub